First Trust Advisors LP Sells 46,390 Shares of Option Care Health, Inc. (NASDAQ:OPCH)

First Trust Advisors LP lessened its holdings in Option Care Health, Inc. (NASDAQ:OPCH - Free Report) by 45.3% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 56,116 shares of the company's stock after selling 46,390 shares during the quarter. First Trust Advisors LP's holdings in Option Care Health were worth $1,302,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other large investors have also recently made changes to their positions in the business. Wellington Management Group LLP raised its holdings in Option Care Health by 84.6% during the 4th quarter. Wellington Management Group LLP now owns 18,325,123 shares of the company's stock valued at $425,143,000 after acquiring an additional 8,400,208 shares during the period. Norges Bank bought a new stake in shares of Option Care Health during the 4th quarter valued at $60,219,000. Victory Capital Management Inc. lifted its holdings in Option Care Health by 31.1% during the 4th quarter. Victory Capital Management Inc. now owns 2,125,433 shares of the company's stock worth $49,310,000 after purchasing an additional 503,840 shares in the last quarter. Magnetar Financial LLC boosted its position in shares of Option Care Health by 23.1% in the fourth quarter. Magnetar Financial LLC now owns 2,350,598 shares of the company's stock valued at $54,534,000 after acquiring an additional 441,265 shares during the period. Finally, Trexquant Investment LP bought a new position in shares of Option Care Health in the fourth quarter worth $10,161,000. 98.05% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

Several analysts have recently weighed in on OPCH shares. Barrington Research restated an "outperform" rating and set a $38.00 price objective on shares of Option Care Health in a research report on Wednesday, April 30th. Bank of America upgraded shares of Option Care Health from a "neutral" rating to a "buy" rating and upped their price target for the company from $26.00 to $33.00 in a report on Monday, January 13th. JMP Securities reaffirmed a "market outperform" rating and issued a $36.00 price target on shares of Option Care Health in a research note on Tuesday, April 22nd. UBS Group raised shares of Option Care Health from a "neutral" rating to a "buy" rating and boosted their price objective for the company from $38.00 to $40.00 in a research report on Wednesday, April 30th. Finally, JPMorgan Chase & Co. raised their target price on shares of Option Care Health from $40.00 to $41.00 and gave the stock an "overweight" rating in a research report on Thursday, March 6th. One equities research analyst has rated the stock with a hold rating and seven have given a buy rating to the stock. Based on data from MarketBeat, Option Care Health has an average rating of "Moderate Buy" and an average price target of $35.50.

Option Care Health Stock Up 0.4 %

OPCH stock traded up $0.14 during trading on Friday, hitting $31.84. 1,566,842 shares of the stock traded hands, compared to its average volume of 1,840,162. The firm's 50 day moving average is $33.24 and its two-hundred day moving average is $28.90. Option Care Health, Inc. has a 1 year low of $21.39 and a 1 year high of $35.53. The stock has a market cap of $5.21 billion, a price-to-earnings ratio of 26.76, a price-to-earnings-growth ratio of 2.30 and a beta of 0.76. The company has a debt-to-equity ratio of 0.77, a current ratio of 1.73 and a quick ratio of 1.32.

Option Care Health (NASDAQ:OPCH - Get Free Report) last posted its quarterly earnings data on Tuesday, April 29th. The company reported $0.40 EPS for the quarter, topping the consensus estimate of $0.36 by $0.04. Option Care Health had a return on equity of 15.30% and a net margin of 4.37%. The firm had revenue of $1.33 billion during the quarter, compared to analyst estimates of $1.26 billion. During the same period in the prior year, the business posted $0.26 EPS. Option Care Health's revenue was up 16.3% on a year-over-year basis. On average, sell-side analysts anticipate that Option Care Health, Inc. will post 1.22 EPS for the current year.

Insider Buying and Selling

In related news, insider Michael Bavaro sold 30,996 shares of Option Care Health stock in a transaction that occurred on Friday, February 28th. The stock was sold at an average price of $33.26, for a total transaction of $1,030,926.96. Following the sale, the insider now owns 44,974 shares of the company's stock, valued at approximately $1,495,835.24. This trade represents a 40.80 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. 0.64% of the stock is currently owned by insiders.

Option Care Health Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.